AbCellera Biologics Inc.

Industry

  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Technologies
      • Genomics-Proteomics
    • Large Molecule
      • Antibodies
    • Gene Therapy, Cell Therapy
  • Digital Health
    • Artificial Intelligence
  • Research, Analytical Equipment & Supplies

Other Names/Subsidiaries

  • TetraGenetics
  • TRIANNI
See more in Biomedtracker

Latest on AbCellera Biologics Inc.

Scrip

Deal Watch: Eyenovia Looks At New Direction In Proposed Merger With Betaliq

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Eyenovia, Betaliq Will Have Combined C

Scrip

Finance Watch: More Than $4.2bn Raised Across Four New VC Funds

 
• By Mandy Jackson

September ended and October began with an explosion of new venture capital available for biotech companies, raising expectations for VC fundraising by drug developers through the rest of 2024, especia

Scrip

Deal Watch: Biogen, AbCellera Team To Find Novel Way To Cross Blood-Brain Barrier

 
• By Joseph Haas and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Biogen’s Pact With AbCellera Will Focus

In Vivo

Will AI Expertise Push Canada Forward As A Biopharma Hub?

 
• By David Wild

With a population one-tenth the size of the US, Canada often sits in the shadow of its neighbour to the south. But when it comes to the quality of its life sciences research and biotech innovation, it